Skip to content

Welcome to Discover Pharma! Today is : October 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Research & Development
  • Therapeutic Areas
  • Uncategorised
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Merck highlights RDKit’s role in AI-driven drug discovery

    read more
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Research & Development,Therapeutic Areas

    Novadip secures €10.4M to advance pivotal Phase 3 trial

    read more
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Telix to acquire ITM in $1.65BN radiopharmaceutical deal

    read more
  • Advanced Therapies,Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome

    read more
  • Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Ariadne Bio launches with Parkinson’s apathy drug candidate

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    MaaT Pharma to advance Phase 3 trial after EMA rejects MaaT013 application

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Manufacturing & Supply Chain,Research & Development

    Saudi Arabia announces biotech deals and research partnerships worth SAR 5.5BN

    read more
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Big Picture Bio launches with £2.2M to design cancer drug combinations

    read more
  • Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    SKY-0515 shows 1.59-point cUHDRS difference in Huntington’s disease study

    read more
  • Advanced Therapies,Biotech & Pharma Business,Research & Development

    Oncodesign Services and Nexus BioQuest form preclinical research partnership

    read more
  • Genomics and sequencing,Research & Development,Therapeutic Areas

    Nabsys EGM detects genomic abnormalities in five-sample leukemia study

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Pharmaceuticals and therapeutics,Research & Development

    Calibre secures CQC registration for nationwide AI health service

    read more
  • Drug Discovery & Development

    Cyllene gene therapy for bladder disorder gains FDA RMAT designation

    read more
  • Digital & Data,Drug Discovery & Development,Research & Development,Therapeutic Areas

    Passive cough monitoring linked to worsening asthma symptoms

    read more
  • Advanced Therapies,Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    NIH funds expanded access programme for Neurizon’s ALS therapy

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Sapience Therapeutics gets FDA clearance for ST316 FAP study

    read more
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Laverock Therapeutics expands into in vivo CAR-T and genetic medicine
    Categories: Advanced Therapies, Central Nervous System, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Trixeo approved in EU for asthma
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Merck highlights RDKit’s role in AI-driven drug discovery
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top